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Diabetic neuropathy is an important complication of the disease, responsible for ulceration and amputation of the foot.
Prevention of these problems is difficult mainly because there is no method to correctly access sensibility on the skin
of the foot.
The introduction of the Pressure-Specified Sensory Device (PSSDTM) in the last decade made possible the measurement
of pressure thresholds sensed by the patient, such as touch, both static and in movement, on a continuous scale.
This paper is the first in Brazil to report the use of this device to measure cutaneous sensibility in 3 areas of the foot: the
hallux pulp, the calcaneus, and the dorsum, which are territories of the tibial and fibular nerves.
METHOD: Non-diabetic patients were measured as controls, and 2 groups of diabetic patients – with and without
ulcers – were compared. The PSSDTM was used to test the 3 areas described above. The following were evaluated: 1 PS (1-
point static), 1 PD (1-point dynamic), 2 PS (2-points static), 2 PD (2-points dynamic).
RESULTS: The diabetic group had poorer sensibility compared to controls and diabetics with ulcers had poorer
sensibility when compared to diabetics without ulcers.
The differences were statistically significant (P <.001).
CONCLUSION: Due to the small number of patients compared, the results should be taken as a preliminary report.
KEY WORDS: Diabetic neuropathies. Diabetes mellitus. Diabetic foot.
Changes in cutaneous sensibility
of lower extremities present in diabetic
neuropathy play an important role in
the incidence of complications and on
the overall morbidity of diabetes.
About 15% of the diabetic popu-
lation will develop ulcerations on their
lower extremities, usually complicated
by infection and a slower healing rate.
This eventually leads to the amputa-
tion of lower extremities.1 Moreover,
amputations are more frequent in dia-
betic patients than in the non-diabetic
population.2
The explanation of how diabetes
causes nerve injury is not completely
clear. Contributing factors include
metabolic injury due to the
hyperglycemia, immunological fac-
tors, and microvascular damage to the
blood supply of the nerve.3-5
A recent theory associates these
“intrinsic” causes to an “extrinsic” fac-
tor, namely the chronic compression
sustained by the swollen nerve when
it transits through anatomic tunnels,
like the tarsal tunnel.6,8
Diabetic neuropathy has been con-
sidered irreversible, with no known
treatment available.9 However, meas-
urement of the degree of sensory im-
pairment is paramount for the estab-
lishment of preventive measures to
avoid ulceration. Moreover, although
neuropathy is bilateral, the symptoms
may affect the two feet to different de-
grees.
Dellon et al.10,11 made the proposal
to use surgical release of tarsal tunnel
to decompress the tibial nerve in the
diabetic who has neuropathy symp-
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toms and evidence of sensory nerve
compression, adding thereby another
important need for a more precise
evaluation of the sensory deficit.
Measurement of cutaneous sensi-
bility has been undertaken by instru-
mentation that assesses temperature
threshold, but the sensation of touch
is more important on the foot in order
to prevent ulceration.
Pain and temperature are conducted
by thin unmyelinated (A delta fibers),
whereas sensation of touch is con-
ducted by A beta fibers, which can be
divided into slowly and quickly
adapting fibers that are related to spe-
cific receptors.
On the skin, continuous pressure,
which stimulates Ruffini and Merkel
terminations, is transmitted by slow-
adapting fibers. Vibration, on the other
hand, exerts a quick stimulus to the
Meissner and Paccini receptors, which
is transmitted by fast-adapting fibers
and is felt by the patient as moving
touch.9 This stimulus is a wave form
and will stimulate the peroneal nerve
on the dorsum of the foot, and the
tibial nerve on the plantar aspect of the
foot at the same time.
Perception of touch was first meas-
ured using pressure of Von Frey hair fila-
ments, but this approach has been re-
placed worldwide by the Semmes –
Weinstein nylon monofilaments. They
are rods of different sizes and are use-
ful for determining the threshold of
pressure, represented by a certain diam-
eter, below which the patient does not
feel touch. This touch stimulus is per-
ceived only by the piece of skin being
stimulated, in contrast to vibration.
Semmes-Weinstein filaments are
part of most endocrinologists’ arma-
mentarium, and the specific size that
gives a force of 10 g is considered as
the upper limit of a sensible foot for
diabetics. This filament has a logarith-
mic value of 5.07. Semmes-Weinstein
filaments, however, do not supply a
continuous graduation and so the
evaluation is less precise; they just
give an estimate of a range.
Moving touch may be assessed by
a vibrometer, but the device is not
regularly employed by the average
physician.9
An important contribution was the
Disk-CriminatorTM (Fig. 1) to evaluate
the so-called 2-point discrimination,
routinely used in nerve injuries to the
hand but only recently applied to the
foot of diabetic patients.12
The test measures the minimum dis-
tance of separation in mm that the pa-
tient reports feeling the 2 points of the
instrument touching the skin.13 It is also
useful for predicting the severity of the
neuropathy, since it assesses the density
of innervations on that specific area.
However, different examiners may ap-
ply it to the skin at different pressures,
resulting in ambiguity.
In the 1990s, Dellon proposed a
new device, the Pressure-Specified
Sensory DeviceTM (PSSD) (Fig. 2) that
could gather information about static
and moving touch in a continuous
form by using a computer. This device
specified the pressure at which 1 point
would be distinguished from 2 points,
resolving the conflicts mentioned
above.
Associating the concept of 2-point
discrimination as given by the Disk-
Criminator with the PSSDTM, both
thresholds of touch and density of
fibers could be more precisely eva-
luated.
The PSSDTM has been used to as-
sess sensation of many areas of the
body, especially in hand surgery.14 We
introduced the device in the Hospital
das Clínicas-FMUSP in 1999, and
since then it has been used to study the
sensibility of the skin on the face,
hand, and on the breast after reduction
mammaplasty.15
Measuring sensation on the feet of
diabetic patients seemed a natural ex-
tension of that research. A first project
was planned in order to evaluate the
sensibility on the foot among nondia-
betic patients, diabetics without ul-
ceration, and those with ulcers on the
lower extremity.
The purpose of this paper is to re-
port the preliminary findings.
METHOD
We evaluated sensibility on the
feet of 28 patients. The mean age was
54 years (38 to 62). Seventeen were
women and 11 men.
Ten patients were used as controls,
since they were not considered to be
diabetic (they had normal blood sugar
levels, and they presented no symp-
toms).
Ten other patients were diabetic,
controlled by medication, and never had
an ulceration on the lower extremity.
Eight patients were diabetic and ex-
hibited chronic ulcer on only one foot.
Figure 1 - Disk-CriminatorTM
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Evaluation of sensibility
Sensibility was measured using the
PSSDTM (Fig. 2) and the Disk-
criminatorTM (Fig. 1) as suggested by
Seiler et al.12 The minimum distance of
2 points perceived by the patient is as-
sessed using the Disk-Criminator.
The PSSDTM consists of a structure
with parallel metallic prongs that can
be positioned at the specific distance
in millimeters. The patient is put in a
comfortable reclining position and
asked to report (pressing a button)
when feeling the pressure of either 1
point or with 2 points exerted by the
examiner’s hand. The results are inte-
grated by a computer. The distance the
patient can first discriminate 2 discrete
points with the Disk-CriminatorTM is
taken as the distance to begin testing
with the PSSDTM.
Therefore, 6 thresholds can be ob-
tained in a specific area of the foot: 2-
point minimum distance in mm, both
static and moving; 1-point pressure,
static and moving (g/mm2) and 2-point
pressure threshold, both static and
moving (Table 1).
The tests were done in 3 areas (Fig.
3, Fig. 4, Fig. 5):
a) hallux pulp, territory of the medial
plantar branch of the posterior
tibial nerve.
b) calcaneus, over the medial aspect
of the foot to avoid the thick epi-
dermis, territory of the calcaneal
branch of the tibial nerve.
c) first commissure on the dorsum of
the foot¯area of the deep branch of
the fibular nerve.
The results of the test were submit-
ted to statistical analysis by the
ANOVA method: control versus dia-
betic without ulcer, control versus dia-
betic with ulcer, and between the 2
groups of diabetics.
The significance level was set at P
<.001.
RESULTS
The results obtained with the 2-
point discrimination are shown on Ta-
ble 2. The PSSD results are shown on
Table 1.
Discrimination in nondiabetic pa-
tients (controls) was about 8 mm in
plantar areas, similar to the findings in
diabetic group without ulcer, but lower
than in the group with ulcers, which
had discriminations of about 14 mm.
The mean data with the PSSD on
the plantar area of the hallux for 1
static and moving point were: normal–
1.29 g/mm2 and 1.20 g/mm2; diabetic,
no ulcer–35.10 g/mm2 and 21 g/mm2;
and for diabetic, with ulcer–78.04 g/
mm2 and 59.94 g/mm2.
Data for 2-point thresholds for
static and moving points were: normal–
15.82 g/mm2 and 8.90 g/mm2; dia-
betic, no ulcer–23.26 g/mm2 and 21.19
g/mm2; and diabetic with ulcer¯43.41
g/mm2 and 40.99 g/mm2.
Comparisons of groups had statis-
tical significance with P <.001.
DISCUSSION
Evaluation of sensibility on the
feet of diabetic patients is of para-
Table 1 - Pressure-Specified Sensory
Device (PSSDTM)  results (g/mm2).
PSSD Hallux Dorsum Calcaneus
1PS ND 1.3 2.1 1.3
D1 35.1 20.3 30.5
D2 78.0 37.9 47.7
1PD ND 1.2 2.0 1.2
D1 21.0 13.5 20.4
D2 59.9 31.0 33.3
2PS ND 15.8 16.5 17.2
D1 23.2 30.0 20.6
D2 43.4 53.1 30.0
2PD ND 8.9 9.8 9.4
D1 21.2 27.7 19.4
D2 41.0 39.0 32.1
1PS: 1 Point Static
1PD: 1 Point Dinamic
2PS: 2 Point Static
2PS: 2 Point Dinamic
ND: Nondiabetics
D1: Diabetics without ulceration
D2: Diabetics with ulceration
Figures 3, 4, 5 - Demonstration of measure-
ments in the three different areas: hallux pulp,
first comissure at the feet dorsum and medial
calcaneus (APUD: Dellon AL, Somatosensory
testing and rehabilitation. Baltimore Institute
for peripheral nerve surgery, 2002)
Table 2 - Disk-criminatorTM results
(mm).
Disk Hallux Dorsum Calcaneus
Static ND 8.4 9.1 8.3
D1 8.2 8.1 7.2
D2 14.3 13.5 9.6
Dinamic ND 7.2 8.1 7.3
D1 7.2 6.3 5.1
D2 13.7 13.3 8.9
ND: Nondiabetics
D1: Diabetics without ulceration
D2: Diabetics with ulceration
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mount importance in order to provide
proper identification of the group with
neuropathy and to establish prevention
of ulceration for those at risk.
Measurement of touch perception
as conferred by receptors to pressure
and vibration has been traditionally
performed by Semmes-Weinstein
mono-filaments and vibrometers, but
the results are not precise enough to
determine the degree of neuropathy or
to diagnose those with additional
nerve compression.
The PSSDTM represents, associated
with the assessment of 2-point dis-
crimination, a modern method for
evaluating sensibility in diabetics.
The method is subjective, since the
patient must report whether or not the
pressure is felt, but it is more reliable
than the previously available methods
and gives data in a continuous range.
The present paper is the first com-
munication of the use of this device in
Brazil to assess sensibility on diabetic
feet; consequently, the results should
be taken as a preliminary report.
In the first group of patients, who
were not diabetic, the data can be con-
sidered as normative and is compara-
ble to that published for Caucasians
from the U.S.A. in 1996.16,17 Therefore,
this data was used as the control group
for the data obtained from the diabetic
population.
It was clear that average 2-point
discrimination distance for the control
group was about 8 mm, a value con-
sidered to be normal for fiber density
on those areas in patients above the
age of 45 years.
Some patients of the diabetic
group remained at this level, but
clearly, patients with ulcers had higher
numbers, indicating chronic loss of
axons.
PSSD data, both static and moving,
1- or 2-point touch evaluations,
showed increased thresholds in the
diabetic population when compared
with the control group, and within the
diabetic group, thresholds were even
higher in patients who had ulcerations,
and differences in both were statisti-
cally significant, P <.001.
The abnormal values found in our
diabetics with and without ulcers were
similar to those reported by Tassler
and Dellon in 1995.16
The tests, as presented here, will
represent an important tool to help
doctors achieve better control with
diabetic patients and establish preven-
tive measures that will improve qual-
ity of life for their patients.
RESUMO
FERREIRA MC e col. Novo método
para avaliação da sensibilidade cutâ-
nea do pé diabético. Relato preli-
minar. Rev. Hosp. Clín. Fac. Med.
S. Paulo 59(5):286-290, 2004.
A neuropatia diabética é uma
complicação importante do Diabetes
melitus, responsável por ulcerações e
amputações de membros inferiores.
A prevenção desses problemas é
difícil principalmente pela ausência de
métodos que avaliem de forma precisa
a sensibilidade cutânea dos pés.
A introdução do PSSDTM (Pressure-
Specified Sensory Device) na década
passada tornou possível a medição dos
limiares cutâneos de pressão. Estes são
sentidos como estímulos táteis tanto
estáticos como dinâmicos.
Este artigo é o primeiro no Brasil
a relatar o uso do PSSDTM para avaliar
3 áreas dos pés: polpa do hallux,
calcâneo e dorso do pé, territórios de
inervação dos nervos tibial e fibular.
MÉTODO: Pacientes não diabéti-
cos foram utilizados como grupo con-
trole e dois grupos de pacientes dia-
béticos – sem úlcera e com úlcera - fo-
ram analisados. O PSSDTM foi utiliza-
do em 3 modalidades: 1 PS (1 Ponto
Estático), 1 PD (1 Ponto dinâmico), 2
PS (2 pontos estáticos), 2 PD (2 Pon-
tos Dinâmicos). Foram avaliadas as 3
áreas citadas acima.
RESULTADOS: Foi observada
pior sensibilidade em pacientes diabé-
ticos, especialmente no grupo de pa-
cientes com úlceras de membros infe-
riores. As diferenças foram estatistica-
mente significantes (p<0,001).
CONCLUSÃO: Devido ao peque-
no número de pacientes os resultados
devem ser considerados como relato
preliminar.
UNITERMOS: Neuropatias diabé-
ticas. Diabetes mellitus. Pé diabético.
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